Aquestive Therapeutics, Inc. ($AQST)
Filing Information
| Accession Number | 0001214659-26-003142 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 11, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
133,241
Total Value
$248,012.19
P&L
+156.5% (+$285,325.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Mar 9, 2026 | Grant/Award | 75,000 | $0.00 | $0.00 | 256,858 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Mar 10, 2026 | Sale | 15,741 | $4.17 | $65,687.19 | 241,117 | Direct | โ | View Details | |
Chief Commercial Officer | Non-Qualified Stock Option (right to buy) | Derivative | Mar 9, 2026 | Grant/Award | 42,500 | $4.29 | $182,325.00 | 42,500 | Direct | โ | View Details |